M&T Bank Corp Regeneron Pharmaceuticals, Inc. Transaction History

M&T Bank Corp

$28.6 Billion
Q1 2024

A detailed history of M&T Bank Corp transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, M&T Bank Corp holds 5,570 shares of REGN stock, worth $5.85 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

5,570

Previous 5,329 4.52%

Holding current value

$5.85 Million

Previous $4.68 Million 14.55%

% of portfolio

0.02%

Previous 0.02%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$902.69 - $993.35 $217,548 - $239,397	241 Added 4.52%	5,570 $5.36 Million
Q4 2023 Feb 06, 2024	SELL	$775.18 - $881.7 $72,866 - $82,879	-94 Reduced 1.73%	5,329 $4.68 Million
Q3 2023 Nov 02, 2023	BUY	$692.45 - $844.37 $17,311 - $21,109	25 Added 0.46%	5,423 $4.46 Million
Q2 2023 Aug 09, 2023	BUY	$700.03 - $830.35 $1,400 - $1,660	2 Added 0.04%	5,398 $3.88 Million
Q1 2023 May 11, 2023	BUY	$680.49 - $826.97 $611,760 - $743,446	899 Added 19.99%	5,396 $4.43 Million

Q4 2022 Feb 13, 2023	BUY	$705.89 - $766.39 $8.59 Million - $9.33 Million	12,172 Added 234.44%	17,364 $12.5 Million
Q4 2022 Feb 13, 2023	SELL	$705.89 - $766.39 $9.08 Million - $9.86 Million	-12,867 Reduced 74.1%	4,497 $3.24 Million
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $417,850 - $527,304	-728 Reduced 12.3%	5,192 $3.41 Million
Q2 2022 Aug 05, 2022	BUY	$548.35 - $738.84 $911,357 - $1.23 Million	1,662 Added 39.03%	5,920 $2.87 Million
Q1 2022 May 09, 2022	BUY	$595.12 - $698.43 $14,878 - $17,460	25 Added 0.59%	4,258 $2.98 Million
Q4 2021 Feb 07, 2022	BUY	$543.48 - $670.97 $10,326 - $12,748	19 Added 0.45%	4,233 $2.67 Million
Q3 2021 Oct 28, 2021	BUY	$574.03 - $680.96 $87,252 - $103,505	152 Added 3.74%	4,214 $2.55 Million
Q2 2021 Aug 13, 2021	SELL	$472.8 - $558.54 $16,075 - $18,990	-34 Reduced 0.83%	4,062 $2.27 Million
Q1 2021 May 06, 2021	SELL	$446.73 - $548.2 $665,180 - $816,269	-1,489 Reduced 26.66%	4,096 $1.94 Million
Q4 2020 Feb 12, 2021	SELL	$478.3 - $607.98 $301,807 - $383,635	-631 Reduced 10.15%	5,585 $2.7 Million
Q3 2020 Nov 06, 2020	SELL	$544.75 - $658.21 $564,361 - $681,905	-1,036 Reduced 14.29%	6,216 $3.48 Million
Q2 2020 Jul 29, 2020	SELL	$493.32 - $643.92 $418,335 - $546,044	-848 Reduced 10.47%	7,252 $4.52 Million
Q1 2020 May 14, 2020	SELL	$336.18 - $494.43 $304,579 - $447,953	-906 Reduced 10.06%	8,100 $3.95 Million
Q4 2019 Feb 07, 2020	BUY	$274.13 - $376.51 $149,400 - $205,197	545 Added 6.44%	9,006 $3.38 Million
Q3 2019 Nov 12, 2019	BUY	$273.46 - $318.39 $986,917 - $1.15 Million	3,609 Added 74.38%	8,461 $2.35 Million
Q2 2019 Aug 12, 2019	SELL	$299.6 - $414.82 $464,080 - $642,556	-1,549 Reduced 24.2%	4,852 $1.52 Million
Q1 2019 May 15, 2019	SELL	$372.08 - $439.57 $5,581 - $6,593	-15 Reduced 0.23%	6,401 $2.63 Million
Q4 2018 Feb 01, 2019	SELL	$335.82 - $403.04 $461,080 - $553,373	-1,373 Reduced 17.63%	6,416 $2.4 Million
Q3 2018 Nov 09, 2018	BUY	$351.14 - $408.51 $121,494 - $141,344	346 Added 4.65%	7,789 $3.15 Million
Q2 2018 Aug 10, 2018	SELL	$284.6 - $344.99 $190,682 - $231,143	-670 Reduced 8.26%	7,443 $2.57 Million
Q1 2018 May 04, 2018	SELL	$315.82 - $393.78 $2.25 Million - $2.8 Million	-7,114 Reduced 46.72%	8,113 $2.79 Million
Q4 2017 Feb 06, 2018	SELL	$358.63 - $469.95 $839,552 - $1.1 Million	-2,341 Reduced 13.33%	15,227 $5.73 Million
Q3 2017 Nov 13, 2017	SELL	$431.38 - $504.0 $823,073 - $961,632	-1,908 Reduced 9.8%	17,568 $7.86 Million
Q2 2017 Aug 11, 2017	BUY	N/A	19,476	19,476 $9.57 Million

Others Institutions Holding REGN

# of Institutions

1,424

Shares Held

82.1M

Call Options Held

835K

Put Options Held

1.46M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $113B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.

Account